On April 15, 2021, RISE Life Science Corp. (CNSX:RLSC) closed the transaction. The company amended the terms of the transaction. The company issued 621 subscription receipts at an issue price of $1,000 per subscription receipt for gross proceeds of $621,000 in its second and final tranche. The company received $1,331,000 in the transaction.